Zhenhua Xu

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Oxidative Stress

Ulcerative Colitis

Atopic Dermatitis

Top Venues

Clinical pharmacology and therapeutics

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Yanli Zhuang, Cesar Calderon, Stanley J Marciniak, Esther Bouman-Thio, Philippe Szapary, Tong-Yuan Yang, Allen Schantz, Hugh M Davis, Honghui Zhou, Zhenhua Xu
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis. European journal of clinical pharmacology 72 (11) (2016)